an antineoplastic agent, prescribed for treating a type of non-small cell lung cancer with a specific genetic marker. Tagrisso / Osimertinib may also be used for other purposes as advised by a prescribing physician.
Tagrisso is a cancer medication prescribed for the treatment of a kind of non-small cell lung cancer with EGFR T790M mutation. It works by inhibiting the growth and further spread of the cancer cells.
Tagrisso is generally prescribed after other treatments have not shown successful results.
What could be the side effects resulting from taking Tagrisso / Osimertinib?
If you experience signs of an allergic reaction such as swelling in the mouth, face, tongue, throat or lips, difficulty in breathing and/or hives, seek immediate medical attention.
Inform your doctor if you have:
Shortness of breath and/or pounding heartbeats
• Light-headedness
• Rapidly gaining weight and/or swelling
• Symptoms of worsening lung health: dry coughs, pain in the chest, wheezing and/or shortness of breath
• Problems in eyes: pain in the eye, redness of the eyes and/or change in vision
Showing certain side effects can lead to delays or permanent discontinuation of treatment with Tagrisso
Some of the more common side effects include:
• Rashes, mouth sores and/or dry skin
• Tiredness
• Diarrhea
• Loss of appetite
• Infections and other problems with your toenails and/fingernails
Not all the side effects from Tagrisso are listed here. For more information about the possible side effects, contact your doctor.
What are the key things to know about Osimertinib / Tagrisso?
Taking Tagrisso can be the cause of lung problems that may even result in death. The symptoms of such problems can be similar to symptoms of lung cancer. Contact your doctor immediately if you are experiencing symptoms of worsening lung health like shortness of breath, continuous coughing and/or fever.
Taking Tagrisso can also be the cause of lung problems that may even result in death. Your doctor would check your heart functions before prescribing this medication. Contact your doctor immediately if you are experiencing signs of heart problems such as shortness of breath, light-headedness and/or swelled ankles & feet
What are the things that my healthcare provider should be informed about before taking Branded Drug Tagrisso / Generic Osimertinib?
If you are allergic to this Osimertinib, your treatment should not include Tagrisso.
To be certain that Tagrisso is safe to use, tell your doctor if you ever had/have:
• A breathing disorder
• Eye problems
• A medical history of long QT syndrome in the family
• Electrolyte imbalance
This medication can harm the unborn baby if either parent are taking it.
For men, use effective birth control during your treatment with Osimertinib / Tagrisso and for at least 4 months after taking the last dose.
For women, use effective birth control during your treatment with Osimertinib / Tagrisso and for at least 6 weeks after taking the last dose. Do not take this medication if you are pregnant.
Contact your doctor immediately if pregnancy does occur while either partner was taking this medication.
It is unknown whether or not Osimertinib can pass through breast milk. As such, breastfeeding is not recommended during the treatment and at least 2 weeks after the last dose to prevent harm to the nursing baby.
More Information on Osimeritinb / Tagrisso
Popular Search Keywords For Osimertinib / Tagrisso:
Get #Osimertinib #Tagrisso Medication Worldwide Online in 2-5* working DaysPlace an Order at https://bit.ly/3zgSCG1#pharma #medication #pharmaceutical #pharmacy #store #Cancer #COPD #CKD #diabetes #hepatitis #antiviral #cholestrol #anticoagulants
Find tagrisso osimertinib price online at CancerCurePharmacy.com, Buy tagrisso 40 mg and osimertinib 80 mg at an economical Price, osimertinib tagrisso, Read more Information about tagrisso lung cancer - tagrisso osimertinib.
Lung Cancer is the cause of nearly 1.6 million cancer deaths around the world every year.
It is generally caused by malignant cell growing in the bronchi or airways inside the lungs.
A type of lung cancer known as non-small cell lung cancer is responsible for nearly 85% of the lung cancer cases.In some non-small cell lung cancer cases, the patient may have an abnormal protein in the tumor known as epidermal growth factor receptor or EGFR.
Such mutated receptor may lead to the tumor growing uncontrollably.In such cases, certain medications are used to block the mutated receptor known as EGFR tyrosine kinase inhibitors or EGFR TKIs.
However, such medications are inefficient in the treatment of lung cancer patients who have a particular mutation known as T790M mutationLung Cancer Treatment with TagrissoTagrisso medication contains an active substance called Osimertinib that belongs to the anti-cancer class of medications known as protein kinase inhibitor.
This substance blocks the mutated receptor in patients who have a T790M mutation to further inhibit the tumor growth.The branded medication Tagrisso is manufactured by AstraZeneca and approved in over 70 countries including USA, UK, China and Japan.
